This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Aalto University, Arivin Therapeutics Oy. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Ekaterina Osmekhina: Innovator in Microbial Signaling Inhibition
Introduction
Ekaterina Osmekhina is a prominent inventor based in Aalto, Finland. She has made significant contributions to the field of microbial signaling, particularly through her innovative research and inventions. Her work focuses on developing methods to inhibit gram-negative bacterial quorum signaling molecules, which has important implications for medical and environmental applications.
Latest Patents
Osmekhina holds a patent for a method of inhibiting gram-negative bacterial quorum signaling molecules using the macrocycle pillar[5]arene. This invention relates to macrocyclic cavity-containing compounds and their use in inhibiting microbial signaling molecules or reducing their amounts in a subject. The patent outlines methods for achieving this inhibition by contacting a macrocyclic cavity-containing compound with the subject, showcasing her innovative approach to tackling microbial challenges.
Career Highlights
Ekaterina Osmekhina is affiliated with the Aalto University Foundation Sr., where she continues her research and development efforts. Her work has garnered attention for its potential to address significant health and environmental issues related to bacterial signaling.
Collaborations
Osmekhina collaborates with notable colleagues, including Christopher Jonkergouw and Kodiah Beyeh, who contribute to her research endeavors. Their combined expertise enhances the impact of her work in the field of microbial signaling.
Conclusion
Ekaterina Osmekhina is a trailblazer in the field of microbial signaling inhibition, with a patent that demonstrates her innovative approach to addressing bacterial challenges. Her contributions to science and collaboration with esteemed colleagues position her as a key figure in this important area of research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile